Effect of Tegoprazan or RAPA113 on Pharmacodynamics/Pharmacokinetics of Clopidogrel in Healthy Male Volunteers

NCT04171687 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Clopidogrel 75mg
DRUG: Tegoprazan 50 mg
DRUG: RAPA113

Sponsor

HK inno.N Corporation